What Is Beta-Endorphin? Benefits, Research & Safety
The body's natural opioid peptide involved in pain modulation, stress response, and reward, mediating the 'runner's high' and other euphoric states.
UK summary: Endogenous opioid peptide. Not a medicine (too short half-life and too central a target). Released in exercise, stress, and pain modulation — this entry is educational background.
Quick Facts
Overview
Beta-Endorphin — evidence and risk at a glance
Twenty standard modules scored against the Peptide Authority evidence grading methodology. Missing modules indicate the field has not yet been characterised editorially — treat absences as uncertainty rather than reassurance.
01Evidence snapshot
Endogenous opioid peptide. Not a medicine (too short half-life and too central a target). Released in exercise, stress, and pain modulation — this entry is educational background.
02Human evidence grade
03Preclinical evidence grade
04Regulatory status
- UK: Not a therapeutic agent. Research compound only.
- EU: Not used therapeutically.
- Notes: β-endorphin is studied as an endogenous substance but not used as a medication due to its opioid properties. Research focuses on understanding the endogenous system rather than administering the peptide.
05Approved medical uses
None in the UK or EU as a finished medicine. (Or: not yet documented; treat as absence rather than approval.)
06Unapproved / promotional claims
- Endorphin supplements lift mood / reduce pain.
- Buy endorphin peptides for natural pain relief.
07Common internet claims
- Sold as 'endorphin supplements' in wellness retail.
- Marketed as a natural mood-lifter peptide.
08Claim vs evidence
| Claim | Evidence | Human evidence? | Regulatory concern | Safer wording |
|---|---|---|---|---|
| “Endorphin supplements lift mood” | E | No | High | Beta-endorphin cannot be taken orally; 'endorphin supplements' have no mechanism. Exercise reliably raises endogenous endorphin levels. |
09Safety uncertainty score
Safety profile partly characterised; some signals from observational or preclinical data.
10Known adverse signals
- Oral endorphin products have no rational mechanism; safety depends on what's actually in the supplement.
11Drug-interaction uncertainty
Some interaction data published; check with a prescriber for your specific medicines.
12Anti-doping status
13UK legal position
Not a therapeutic agent. Research compound only.
14EU legal position
Not used therapeutically.
15What this page cannot tell you
- What 'endorphin supplements' actually contain.
- Whether they produce any measurable effect on endogenous endorphin tone.
16Last reviewed
17Citation quality score
18Research gaps
- Exogenous endorphin pharmacology is not a viable therapeutic route due to BBB and half-life issues.
19Safer alternatives / established care pathways
- Regular exercise — the most reliable evidence-based way to raise endogenous endorphin tone.
- NHS Talking Therapies for mood concerns.
- Pain-clinic referral for chronic pain via GP.
20Doctor discussion prompts
Questions to ask a qualified clinician
These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.
- What evidence-based interventions affect endorphin / pain pathways for my situation?
Discovery & History
Mechanism of Action
Researched Benefits
Based on preclinical and clinical research findings:
- 1Natural pain relief and analgesia
- 2Stress reduction and anxiety relief
- 3Mood elevation and euphoria
- 4Immune system modulation
- 5Regulation of reward and motivation
- 6Mediates benefits of exercise, meditation, and other practices
Claim vs Evidence
How popular claims about Beta-Endorphin stack up against the current research, graded using our public evidence grading methodology.
| Claim | Evidence | Human evidence? | Regulatory concern | Safer wording |
|---|---|---|---|---|
| “Endorphin supplements lift mood” | E | No | High | Beta-endorphin cannot be taken orally; 'endorphin supplements' have no mechanism. Exercise reliably raises endogenous endorphin levels. |
Theoretical Dosing & Protocols
| Theoretical Dosage | Not administered therapeutically due to opioid effects |
| Frequency | N/A |
| Duration | N/A |
| Notes | β-endorphin is not used as a therapeutic agent due to its opioid activity and abuse potential. Research focuses on understanding endogenous endorphin systems and how to enhance natural endorphin release through exercise, meditation, and other means. |
Administration Routes
Routes studied in research settings (educational only):
- Not administered therapeutically
- Research uses intracerebroventricular or intravenous routes in animal studies
| Half-Life | Stability |
|---|---|
| Short in plasma; rapidly degraded by peptidases | Subject to enzymatic degradation; requires careful handling in research |
Safety Profile & Known Risks
Commonly Reported Side Effects
- Not administered therapeutically—effects relate to endogenous release
Rare Risks & Concerns
- Exogenous administration would have opioid effects
- Respiratory depression, sedation
- Physical dependence potential
Contraindications
- Exogenous β-endorphin administration is not a clinical practice
UK & EU Regulatory Context
🇬🇧 United Kingdom
Not a therapeutic agent. Research compound only.
🇪🇺 European Union
Not used therapeutically.
Clinical Studies Summary
Neurophysiological Effects of Dry Needling: A Systematic Review and Meta-analysis.
The application of dry needling can induce significant changes in pain-related biomarker levels in animal and human studies, providing insights into its underlying mechanisms of action and potential clinical effects.
A Systematic Review With Meta-Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia.
Current evidence does not support altered peripheral endorphin levels in FM or cLBP, while emerging PET findings indicate reduced central MOR availability in FM. These results suggest receptor-level dysregulation rather than peripheral opioid deficits.
Association of endogenous hormones with major depressive disorder phenotype: A systematic review and meta-analysis of drug-free case and control cross-sectional study.
This meta-analysis highlights alterations across the HPA/HPT/HPG axes in MDD patients. More studies focusing on these hormonal markers within specific MDD subtypes are warranted to clarify their mechanistic roles and provide stronger evidence of their association with this heterogeneous disorder.
Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder.
No efficacy for stimulants or atomoxetine on negative symptoms is proven. Atomoxetine or amphetamines may improve cognitive symptoms, while methylphenidate should be avoided in patients with schizophrenia. Insufficient evidence is available to draw firm conclusions.
Migraine biomarkers in cerebrospinal fluid: A systematic review and meta-analysis.
Conclusions Glutamate, β-EP, CGRP and NGF concentrations are altered in CSF and, except for NGF, also in blood of migraineurs. Future research should focus on the pathophysiological roles of these compounds in migraine.
Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case-Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors.
GBCC etiopathogenesis is multifactorial (ie, tumor biology, psychosocial factors). BCC production of paracrine neuromediators deserves further study.
Registered Trials & Regulatory Status
7 of 9 completed trials have never posted results. Unreported trials are not neutral: results that go unpublished are more often negative ones.
Effect of Endorphin Massage on Surgical Fear, Anxiety and Pain Before Mastectomy
Status: Not Yet Recruiting · 82 participants · Ataturk University
Conditions: Postoperative Pain, Anxiety, Fear
Plasma Beta-endorphin Levels and Suicidal Behavior
Status: Unknown · 104 participants · University Hospital, Montpellier
Conditions: Suicide, Depression, Beta Endorphin
Does Endorphin Massage Reduce the Anxiety of Pregnant Women?
Status: Unknown · 68 participants · Manisa Celal Bayar University
Conditions: Pregnancy Related
The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels
Status: Completed · 50 participants · TC Erciyes University
Conditions: Birth, Anxiety, Fatigue
Endorphin Massage Application to Women Who Gave Birth Vaginally
Status: Completed · 80 participants · TC Erciyes University
Conditions: Pain, Birth, First
Endorphin at Labor Pain and Acupressure
Status: Completed · 140 participants · Serap ÖZTÜRK ALTINAYAK
Conditions: Labor Pain
The Effect of Foot Reflexology on Pain, Comfort and Beta Endorphin Levels in Patients With Liver Transplantation
Status: Completed · 120 participants · Inonu University
Conditions: Liver Transplant; Complications
Effects of Laughter Yoga on Hemodialysis Patients' Plasma-Beta Endorphin Levels, Pain Levels and Sleep Quality
Status: Completed · 68 participants · Istanbul Sabahattin Zaim University
Conditions: Laughter Yoga, Hemodialysis Patients
Differentiating the Effects of Substance P and Beta-endorphin
Status: Completed · 10 participants · Dartmouth-Hitchcock Medical Center
Conditions: Chronic Obstructive Pulmonary Disease
CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
Status: Completed · 41 participants · Cady, Roger, M.D.
Conditions: Menstrual Migraine
Role of Beta-Endorphin in Cancer Therapy Fatigue
Status: Terminated · 18 participants · Massachusetts General Hospital
Conditions: Breast Cancer, Fatigue
Acute Effects of Acu-Transcutaneous Electrical Nerve Stimulation (Acu-TENS) on Forced Expiratory Flow Volume in One Second (FEV1) and Blood β-Endorphin Level in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status: Completed · 44 participants · The Hong Kong Polytechnic University
Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Adverse event reports (FDA FAERS)
Not applicable: no licensed product contains this peptide, so it is not reported through FAERS. This is an absence of surveillance, not evidence of safety.
Source: ClinicalTrials.gov and openFDA. Updated automatically.
Looking for Beta-Endorphin?
Source research-grade Beta-Endorphin from a trusted UK supplier — third-party tested with certificate of analysis.
View at SupplierFrequently Asked Questions
Questions to ask a qualified clinician about Beta-Endorphin
These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.
- What evidence-based interventions affect endorphin / pain pathways for my situation?
Related Peptides
DSIP
A neuropeptide originally isolated for its sleep-inducing properties, now researched for stress protection, pain modulation, and metabolic effects.
Learn moreACTH
A pituitary hormone that stimulates cortisol production, used diagnostically and therapeutically for various conditions including infantile spasms.
Learn moreAlpha-MSH
A melanocortin peptide with pigmentation, anti-inflammatory, and appetite-regulating effects, the natural basis for several therapeutic developments.
Learn more